Gene editing silences mutant microRNA, restores hearing in adult mice

FHS
July 13, 2024
9:56 am

Researchers have used gene editing to restore hearing in adult mice with a type of inherited hearing loss. They showed that shutting down a damaged copy of a gene called a microRNA (miRNA) enabled the animals to regain hearing. The approach by a research team supported by the National Institutes of Health (NIH), reported in Science Translational Medicine, may eventually lead to potential treatments for inherited hearing loss in people.

LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab – Biotech Investments

EQS-News: Lindis Biotech GmbH / Key word(s): Agreement LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab 19.11.2024 / 10:07 CET/CEST The

November 20, 2024

NewVale unveils $167M fund to back pharma service providers and ‘old ideas that are working’

Growth equity firm NewVale Capital officially broke cover with its $167 million fund on Monday morning to back third-party service providers that support the drug

May 14, 2024

ChatGPT doesn’t know much about drugs, Hims & Hers enters weight-loss market

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

December 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.